Devicare

Barcelona, Spain Founded: 2012 • Age: 14 yrs
Home solutions for chronic disease diagnosis and monitoring are developed.

About Devicare

Devicare is a Retail company based in Barcelona (Spain) founded in 2012. Home solutions for chronic disease diagnosis and monitoring are developed. It operates in the Retail, Technology, and Healthcare sectors. Devicare has raised $7.13 million across 5 funding rounds from investors including Ship2B, Advanced MedTech and Juan Knuth. Its website devicare.com draws about 27 thousand monthly visits. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Monitoring. Its competitors include Beprevent, CARE RESPITE and EmergyON.

Company details

Devicare was founded in 2012 in Barcelona, Spain, within the health technology sector. Portable solutions for the diagnosis, prognosis, treatment, and monitoring of chronic diseases are developed. Products are distributed through partnerships with pharmaceutical and in vitro diagnostic companies. Point-of-care medical devices are utilized to measure biomarkers in body fluids including saliva, tears, sweat, sputum, feces, urine, and blood.

Key Metrics
  • Total Equity Funding
    $7.13M (USD)

    in 5 rounds

  • Latest Funding Round
    $3M (USD), Series A

    Jan 2021

  • Investors
    Ship2B

    & 6 more

Apps and channels of Devicare

Devicare publishes 1 mobile app with over 500 downloads; its YouTube channel Devicare has 478 subscribers and 30 videos.

myLit-Control kidney stones
Google Play Medical Everyone Free 500 downloads
Developer: Devicare SL
View on Google Play
Devicare
YouTube 478 subscribers 30 videos Science & Technology
Open channel

Videos from Devicare

The most watched videos on Devicare's YouTube channel, Devicare (478 subscribers). Click a video to play it here.

Acidificar la orina para prevenir la incrustación recurrente de catéteres dobleJ de larga duración.
482 views
Prevención de la nefrocalcinosi en la acidosis tubular renal distal: a propósito de un caso.
477 views
Lit-Control® pH Up Oral Alcalinization as a Noninvasive Treatment for Uric Acid Stones. Dr. Emiliani
428 views
Lit-Control® pH Down as a Noninvasive Treatment for Encrusted Uropathy. Dr. Kanashiro
296 views

More on Devicare.

Funding Insights of Devicare

Devicare has successfully raised a total of $7.13M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.13M
  • Total Rounds 5
  • Last Round Series A — $3M
  • First Round $850,000

    (May 2016)

  • Investors Count 7

All 5 funding rounds of Devicare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2021$3MSeries A–Advanced MedTech
Mar 2020Seed––
Jun 2017Seed––
May 2017$3.28MSeed––
–
May 2016$850,000Seed––
Valuation history

7 investors in total: 6 institutional and 1 angel.

Investors in Devicare

Devicare has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Ship2B, Advanced MedTech and Juan Knuth.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Social impact investments are facilitated through four acceleration programs.
2013ship2b.orgBarcelona, Spain
emesacorp.es
Customized training programs are provided for sales and customer service teams.
successfulventures.comNew York, United States
Venture capital investments are made in startups by Ona Capital.
onacapital.comManlleu, Spain
Provides medical devices for urology and robotic surgery worldwide.
1990advanced-medtech.comSingapore, Singapore
empresas.info

Juan Knuth

unknown_084a42c71fee4af78
Premium access

Investor details for Devicare

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Devicare

2 people are tracked at Devicare (2 in leadership).

NameRoleGroup
Anna Mas
Director de ventasLeadership
Rosendo Garganta
Chief Executive OfficerLeadership
Premium access

Complete people profiles for Devicare

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Devicare

3 dated milestones of Devicare across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Devicare is founded.
  2. Funding First funding round of $850K.
  3. Funding Latest funding round, Series A, of $3.0M.

Competitors of Devicare

Devicare has 3 listed competitors in our database. They include Beprevent, CARE RESPITE and EmergyON.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
beprevent.es2016Cordoba, Spain
Delivers smart home devices and apps to facilitate connectivity for elders and families.
care-respite.com2014Barcelona, Spain
Monitoring devices for dependent persons are supplied by Care Respite.
emergyon.com2019Huesca, Spain
Develops mobile apps to support senior care and improve daily well-being.
Premium access

Detailed competitors of Devicare

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Devicare

The website of Devicare (devicare.com) receives about 26.7K visits a month.

  • Monthly visits
    26.7K

    ▲ 180.9% vs previous month

Similar websites

Websites whose visitors overlap most with Devicare. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
urologiabe.com
urologiabe.com
100%
#2,059,936–
clinicaitza.com
clinicaitza.com
95%
#1,079,242–
urologofabiangarcia.com
urologofabiangarcia.com
30%
–
clinica-urosalud.es
clinica-urosalud.es
23%
#2,345,943–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Devicare

Devicare was founded in 2012 and raised its 1st funding round 4 years after it was founded.

Devicare is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

Devicare is a funded company, having raised a total of $7.13M across 5 funding rounds to date. The company's 1st funding round was a Seed of $850K, raised on May 2016.

Devicare was founded in 2012 in Barcelona, Spain, within the health technology sector. Portable solutions for the diagnosis, prognosis, treatment, and monitoring of chronic diseases are developed. Products are distributed through partnerships with pharmaceutical and in vitro diagnostic companies. Point-of-care medical devices are utilized to measure biomarkers in body fluids including saliva, tears, sweat, sputum, feces, urine, and blood.

Devicare's top competitors include CARE RESPITE, Beprevent and EmergyON.

Devicare has 7 investors. Key investors include Ship2B, Advanced MedTech, Juan Knuth, EMESA, and AAA Training for Success.

Yes. Devicare publishes myLit-Control kidney stones, with over 500 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available